# US 2018/0023138 A1 · Assays for Single Molecule Detection and Use Thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0023138 A1
- Document ID: US20180023138A1
- Status: Published application
- Kind: A1
- Application number: 15/523,134
- Filed: 2015-10-31
- Published: 2018-01-25
- Earliest claimed: 2014-11-01
- Assignees: Singular Bio, Inc.
- Applicants: Singular Bio, Inc.
- Inventors: Patrick James Collins; Hywel Bowden Jones; Alexandria Hui Wang
- Web page: https://patentgrep.com/patent/US20180023138A1

## CPC

- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q 1/6827: for detection of mutation or polymorphism
- C12Q 1/6837: using probe arrays or probe chips (C12Q1/6874 takes precedence)
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q 2600/158: Expression markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The invention relates to methods of detecting a genetic variation in a genetic sample from a subject. The invention further relates to methods of detecting a genetic variation in a genetic sample from a subject using labeled probes and counting the number of labels in the probes.

## Claims

### Claim 1

A method of isolating a ligated probe set hybridized to a genetic sample, comprising
contacting probe sets to a genetic sample under a condition effective to hybridize the probe sets to a nucleic acid region of interest in nucleotide molecules of the genetic sample, wherein
each of the probe sets comprises a first oligonucleotide probe at the 5′ end of the probe set and a second oligonucleotide probe at the 3′ end of the probe set,
each of the oligonucleotide probes is configured to hybridize to a part of the nucleic acid region of interest,
the first oligonucleotide probe comprises phosphorothioate bonds at four or more nucleotide bonds from the 5′ end, and
the second oligonucleotide probe comprises phosphorothioate bonds at four or more nucleotide bonds from the 3′ end,
ligating the first and second oligonucleotide probes that are hybridized to the nucleotide molecules,
digesting terminal phosphodiester bonds in non-hybridized oligonucleotide probes and/or partially hybridized nucleic acid molecules with one or more exonuclease, and
isolating ligated oligonucleotide probes hybridized to digested nucleic acid molecules from the genetic sample.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the one or more exonuclease comprises a mixture of exonuclease enzymes that digest both double and single-stranded oligonucleotide molecules from 5′ and 3′-end directions.

### Claim 3 (depends on 1, 2)

The method according to any one of claims 1-2, wherein the one or more exonuclease comprises one or more of Exonuclease I, Exonuclease III, Exonuclease VII, Lambda Exonuclease, and T7 Gene 6 Exonuclease.

### Claim 4 (depends on 1, 2, 3)

The method according to any one of claims 1-3, wherein the first and/or second oligonucleotide probe comprises a label.

### Claim 5 (depends on 4)

The method according to claim 4, wherein the label is a fluorescent dye.

### Claim 6 (depends on 1, 2, 3, 4, 5)

The method according to any one of claims 1-5, wherein the first or second oligonucleotide probes comprise a tag.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The method according to any one of claims 1-6, wherein the first or second oligonucleotide probe comprises biotin.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The method according to any one of claims 1-7, wherein the length of the first and second oligonucleotide probes are from 5 to 150 nucleotides.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The method according to any one of claims 1-8, wherein
the probe set further comprises a third oligonucleotide probe that is configured to hybridize to a nucleic acid region in the nucleotide molecules between the nucleic acid regions to which the first and second oligonucleotide probes hybridize, and
the ligating step comprises ligating the first, second and third oligonucleotide probes that are hybridized to the nucleotide molecules.

### Claim 10 (depends on 9)

The method according to claim 9, wherein each of the first, second, and third oligonucleotide probes comprise a label.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The method according to any one of claims 1-10, wherein the genetic sample is isolated from plasma.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

The method according to any one of claims 1-11, wherein the first and second oligonucleotide probes comprise first and second cap structures at the 5′ terminus of the first oligonucleotide probe and 3′ terminus of the second oligonucleotide probe, respectively.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The method according to any one of claims 1-12, wherein
the ligating comprises (i) raising temperature of the probe sets and the nucleotide molecules, and/or (ii) contacting a stabilizing agent to the probe sets and the nucleotide molecules.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The method according to any one of claims 1-12, wherein the ligating comprises raising temperature of the probe sets and the nucleotide molecules to an increased temperature, and contacting a ligation agent to the probe sets at the increased temperature.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The method according to any one of claims 1-12, wherein the ligating comprises raising temperature of the probe sets and the nucleotide molecules to an increased temperature, contacting a stabilizing agent to the probe sets and the nucleotide molecules, and contacting a ligation agent to the probe sets at the increased temperature in the presence of the stabilizing agent.

### Claim 16

A method of detecting a genetic variation in a genetic sample from a subject, comprising
contacting probe sets to a genetic sample under a condition effective to hybridize the probe sets to a nucleic acid region of interest in nucleotide molecules of the genetic sample, wherein
each of the probe sets comprises a first oligonucleotide probe at the 5′ end of the probe set and a second oligonucleotide probe at the 3′ end of the probe set,
each of the oligonucleotide probes is configured to hybridize to a part of the nucleic acid region of interest,
the first oligonucleotide probe comprises phosphorothioate bonds at four or more nucleotide bonds from the 5′ end, and
the second oligonucleotide probe comprises phosphorothioate bonds at four or more nucleotide bonds from the 3′ end,
ligating the first and second oligonucleotide probes that are hybridized to the nucleotide molecules,
digesting terminal phosphodiester bonds in non-hybridized oligonucleotide probes and/or partially hybridized nucleic acid molecules with one or more exonuclease,
detecting non-digested and ligated probe sets to determine the presence or absence of the genetic variation in a genetic sample from a subject.

### Claim 17 (depends on 16)

The method according to claim 16, wherein the one or more exonuclease comprises a mixture of exonuclease enzymes that digest both double and single-stranded oligonucleotide molecules from 5′ and 3′-end directions.

### Claim 18 (depends on 16, 17)

The method according to any one of claims 16-17, wherein the one or more exonuclease comprises one or more of Exonuclease I, Exonuclease III, Exonuclease VII, Lambda Exonuclease, and T7 Gene 6 Exonuclease.

### Claim 19 (depends on 16, 17, 18)

The method according to any one of claims 16-18, wherein the method comprises amplifying the ligated probe sets before the digesting.

### Claim 20 (depends on 16, 17, 18, 19)

The method according to any one of claims 16-19, wherein the first oligonucleotide probe comprises a label and the second oligonucleotide comprises a tag.

### Claim 21 (depends on 16, 17, 18, 19, 20)

The method according to any one of claims 16-20, wherein the first oligonucleotide probe comprises a tag and the second oligonucleotide comprises a label.

### Claim 22 (depends on 21)

The method according to claim 21, wherein the label is a fluorescent dye.

### Claim 23 (depends on 16, 17, 18, 19, 20, 21, 22)

The method according to any one of claims 16-22, wherein the genetic variation is polymorphism.

### Claim 24 (depends on 16, 17, 18, 19, 20, 21, 22, 23)

The method according to any one of claims 16-23, wherein the first or second oligonucleotide probe comprises biotin.

### Claim 25 (depends on 16, 17, 18, 19, 20, 21, 22, 23, 24)

The method according to any one of claims 16-24, wherein the length of the first and second oligonucleotide probe is from 5 to 150 nucleotides.

### Claim 26 (depends on 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The method according to any one of claims 16-25, wherein
the probe set further comprises a third oligonucleotide probe that is configured to hybridize to a nucleic acid region in the nucleic acid molecules between the nucleic acid regions to which the first and second oligonucleotide probes hybridize, and
the ligating step comprises ligating the first, second and third oligonucleotide probes that are hybridized to the nucleotide molecule.

### Claim 27 (depends on 26)

The method according to claim 26, wherein each of the first, second, and third oligonucleotide probes comprises a label.

### Claim 28 (depends on 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)

The method according to any one of claims 16-27, wherein the genetic sample is isolated from plasma.

### Claim 29 (depends on 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)

The method according to any one of claims 16-28, wherein the first and second oligonucleotide probes comprise first and second cap structures at the 5′ terminus of the first oligonucleotide probe and 3′ terminus of the second oligonucleotide probe, respectively.

### Claim 30 (depends on 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)

The method according to any one of claims 16-29, wherein
the ligating comprises (i) raising temperature of the probe sets and the nucleotide molecules, and/or (ii) contacting a stabilizing agent to the probe sets and the nucleotide molecules.

### Claim 31 (depends on 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)

The method according to any one of claims 16-29, wherein the ligating comprises raising temperature of the probe sets and the nucleotide molecules to an increased temperature, and contacting a ligation agent to the probe sets at the increased temperature.

### Claim 32 (depends on 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)

The method according to any one of claims 16-29, wherein the ligating comprises raising temperature of the probe sets and the nucleotide molecules to an increased temperature, contacting a stabilizing agent to the probe sets and the nucleotide molecules, and contacting a ligation agent to the probe sets at the increased temperature in the presence of the stabilizing agent.

### Claim 33

A method of detecting a genetic variation in a genetic sample from a subject, comprising
contacting first and second probe sets to the genetic sample under a condition effective to hybridize the probe sets to a nucleic acid region of interest in nucleotide molecules of the genetic sample, wherein
the first probe set comprises a first labeling probe and a first tagging probe, and the second probe set comprises a second labeling probe and a second tagging probe, and
each of the probes is configured to hybridize to a part of the nucleic acid region of interest in the nucleic acid molecules and comprises phosphorothioate bonds at four or more nucleotide bonds from the 5′ or 3′ end,
hybridizing at least parts of the first and second probe sets to first and second nucleic acid regions of interest in nucleotide molecules of the genetic sample, respectively,
ligating the first probe set by ligating the first labeling probe and the first tagging probe to produce a first ligated probe set comprising the phosphorothioate bonds at the 5′ and 3′ ends,
ligating the second probe set by ligating the second labeling probe and the second tagging probe to produce a second ligated probe set comprising the phosphorothioate bonds at the 5′ and 3′ ends,
digesting terminal phosphodiester bonds in non-hybridized probe sets and/or partially hybridized nucleic acid molecules with one or more exonuclease,
immobilizing the tagging probes to a pre-determined location on a substrate, wherein
the first and second labeling probes and/or the amplified labeling probes thereof ligated to the immobilized tagging probes comprise first and second labels, respectively,
the first and second labels are different,
the immobilized labels are optically resolvable, and
the immobilized first and second tagging probes and/or the amplified tagging probes thereof comprise first and second tags, respectively,
counting (i) a first number of the first label immobilized to the substrate, and (ii) a second number of the second label immobilized to the substrate, and
comparing the first and second numbers to determine the genetic variation in the genetic sample.

### Claim 34

A method of detecting a genetic variation in a genetic sample from a subject, comprising
contacting probes or probe sets to the genetic sample,
hybridizing the probes or probe sets to a nucleic acid region of interest in nucleotide molecules of the genetic sample,
amplifying the probes or probe sets with forward and reverse primers, wherein the forward or reverse primers comprise one or more label,
digesting terminal phosphodiester bonds in single-stranded oligonucleotides of the probes or probe sets with a first exonuclease after the amplifying,
after the digesting with the first exonuclease, inactivating the first exonuclease,
after the inactivating, digesting an end of the amplified double-stranded probes or probe sets with a second exonuclease to produce an amplified single-stranded probe or probe sets, and
after the digesting with the second exonuclease, detecting single-stranded oligonucleotides of the probes or probe sets to determine the presence or absence of the genetic variation in a genetic sample from a subject.

### Claim 35 (depends on 34)

The method according to claim 34, wherein
the probe set is contacted to the genetic sample,
the probe set comprises a labeling probe and a tagging probe, and
the method further comprises ligating the labeling probe and the tagging probe prior to the amplifying.

### Claim 36 (depends on 34, 35)

The method according to any one of claims 34-35, wherein the first exonuclease is Exonuclease I, and the second exonuclease is lambda Exonuclease.

### Claim 37 (depends on 34, 35, 36)

The method according to any one of claims 34-36, wherein the first exonuclease is inactivated by heat.

### Claim 38 (depends on 34, 35, 36, 37)

The method according to any one of claims 34-37, wherein
the probe set is contacted to the genetic sample,
the probe set comprises a labeling probe and a tagging probe,
the method further comprises ligating the labeling probe and the tagging probe prior to the amplifying.
the ligated probe set comprises the labeling probe at the 3′-end and the tagging probe at the 5′-end,
the labeling probe hybridizes to the reverse primer,
the tagging probe comprises the isolating tag,
the tagging probe hybridizes to the forward primer, and
the reverse primer comprises the label.

### Claim 39 (depends on 34, 35, 36, 37, 38)

The method according to any one of claims 34-38, wherein the label is a fluorescent dye.

### Claim 40 (depends on 35)

The method according to claim 35, wherein the lengths of the labeling and tagging probes are from 5 to 150 nucleotides.

### Claim 41 (depends on 34, 35, 36, 37, 38, 39, 40)

The method according to any one of claims 34-40, wherein
the probe set is contacted to the genetic sample, and
the probe set further comprises a gap probe ligated between the labeling and tagging probes.

### Claim 42 (depends on 41)

The method according to claim 41, wherein one or more of the labeling, tagging, and gap probes comprises a label.

### Claim 43

A method of isolating amplified products of a ligated probe set comprising
immobilizing a composition comprising single-stranded ligated probe sets and second probes on a substrate, wherein
each of the single-stranded ligated probe set comprises a labeling probe and a tagging probe ligated to each other,
each of the second probes comprises the labeling probe or the tagging probe, and
the labeling probe or the tagging probe comprises an isolating tag configured to bind to the substrate,
amplifying one or more of the single-stranded ligated probe sets with forward and reverse primers after the immobilizing to form one or more double-stranded ligated probe set, wherein
the forward or reverse primer hybridizing to the labeling probe of the one or more of the single-stranded ligated probe sets comprises a label,
digesting terminal phosphodiester bonds in the second probes and/or the single-stranded ligated probe sets with one or more exonuclease after the amplifying, and
isolating the non-digested and ligated probe sets after the digesting.

### Claim 44 (depends on 43)

The method according to claim 43, wherein the isolating tag is biotin, and the substrate comprises streptavidin.

### Claim 45 (depends on 43, 44)

The method according to any one of claims 43-44, wherein the substrate comprises a streptavidin magnetic bead.

### Claim 46 (depends on 43, 44, 45)

The method according to any one of claims 43-45, wherein
each of the single-stranded ligated probe sets comprises the labeling probe at the 3′-end and the tagging probe at the 5′-end,
the second probes comprise the tagging probe,
the tagging probe comprises the isolating tag,
the labeling probe hybridizes to the reverse primer,
the tagging probe hybridizes to the forward primer, and
the reverse primer comprises the label.

### Claim 47 (depends on 43, 44, 45, 46)

The method according to any one of claims 43-46, wherein the label is a fluorescent dye.

### Claim 48 (depends on 43, 44, 45, 46, 47)

The method according to any one of claims 43-47, wherein the lengths of the labeling and tagging probes are from 5 to 150 nucleotides.

### Claim 49 (depends on 43, 44, 45, 46, 47, 48)

The method according to any one of claims 43-48, wherein
the probe set further comprises a gap probe ligated between the labeling and tagging probes.

### Claim 50 (depends on 49)

The method according to claim 49, wherein one or more of the labeling, tagging, and gap probes comprises a label.

### Claim 51

A method of detecting a genetic variation in a genetic sample from a subject, comprising
contacting single-stranded probe sets to the genetic sample, wherein each of the single-stranded probe sets comprises a labeling probe and a tagging probe, and the labeling probe or the tagging probe comprises an isolating tag configured to bind to the substrate,
hybridizing the single-stranded probe sets to a nucleic acid region of interest in nucleotide molecules of the genetic sample,
ligating the single-stranded probe sets at least by ligating the labeling probe and the tagging probe to produce first single-stranded ligated probe sets,
immobilizing the first single-stranded ligated probe sets on a substrate,
amplifying the first single-stranded ligated probe sets with forward and reverse primers after the immobilizing to form double-stranded ligated probe set, wherein
the forward or reverse primer hybridizing to the labeling probe of the first single-stranded ligated probe set comprises one or more label,
digesting terminal phosphodiester bonds in the single-stranded probe sets with a first exonuclease after the amplifying,
after the digesting with the first exonuclease, inactivating the first exonuclease,
after the inactivating, digesting an end of the amplified double-stranded ligated probe sets with a second exonuclease to produce second single-stranded ligated probe set, and
after the digesting with the second exonuclease, detecting the second single-stranded ligated probe sets to determine the presence or absence of the genetic variation in a genetic sample from a subject.

### Claim 52 (depends on 51)

The method according to claim 51, wherein the first exonuclease is Exonuclease I, and the second exonuclease is lambda Exonuclease.

### Claim 53 (depends on 51, 52)

The method according to any one of claims 51-52, wherein the first exonuclease is inactivated by heat.

### Claim 54 (depends on 51, 52, 53)

The method according to any one of claims 51-53, wherein the isolating tag is biotin, and the substrate comprises streptavidin.

### Claim 55 (depends on 54)

The method according to claim 54, wherein the substrate comprises a streptavidin magnetic bead.

### Claim 56 (depends on 51, 52, 53, 54, 55)

The method according to any one of claims 51-55, wherein
the first single-stranded ligated probe set comprises the labeling probe at the 3′-end and the tagging probe at the 5′-end,
the labeling probe hybridizes to the reverse primer,
the tagging probe comprises the isolating tag,
the tagging probe hybridizes to the forward primer, and
the reverse primer comprises the label.

### Claim 57 (depends on 51, 52, 53, 54, 55, 56)

The method according to any one of claims 51-56, wherein the label is a fluorescent dye.

### Claim 58 (depends on 51, 52, 53, 54, 55, 56, 57)

The method according to any one of claims 51-57, wherein the lengths of the labeling and tagging probes are from 5 to 150 nucleotides.

### Claim 59 (depends on 51, 52, 53, 54, 55, 56, 57, 58)

The method according to any one of claims 51-58, wherein
the probe set further comprises a gap probe ligated between the labeling and tagging probes.

### Claim 60 (depends on 59)

The method according to claim 59, wherein one or more of the labeling, tagging, and gap probes comprises a label.

### Claim 61

A method of detecting a genetic variation in a genetic sample from a subject, comprising
contacting non-ligated first and second probe sets to the genetic sample, wherein each of the first probe sets comprises a first labeling probe and a first tagging probe, and each of the second probe sets comprises a second labeling probe and a second tagging probe,
hybridizing one or more of the first probe set and one or more of the second probe set to first and second nucleic acid regions of interest in nucleotide molecules of the genetic sample, respectively, to produce hybridized first and second probe set,
ligating the hybridized first probe set at least by ligating the first labeling probe and the first tagging probe to produce a ligated first probe set,
ligating the hybridized second probe set at least by ligating the second labeling probe and the second tagging probe to produce a ligated second probe set,
immobilizing one or more of the tagging probes or the labeling probes of each of the non-ligated and ligated probe sets on one or more bead,
amplifying the ligated probe set with forward and reverse primers after the immobilizing, wherein
the forward or reverse primer hybridizing to the labeling probe of the ligated probe set comprises a label,
digesting terminal phosphodiester bonds in non-ligated probes with one or more exonuclease after the amplifying,
immobilizing the tagging probes to a pre-determined location on a substrate, wherein
the first and second labeling probes and/or the amplified labeling probes thereof ligated to the immobilized tagging probes comprise first and second labels, respectively,
the first and second labels are different,
the immobilized labels are optically resolvable, and
the immobilized first and second tagging probes and/or the amplified tagging probes thereof comprise first and second tags, respectively,
counting (i) a first number of the first label immobilized to the substrate, and (ii) a second number of the second label immobilized to the substrate, and
comparing the first and second numbers to determine the genetic variation in the genetic sample.

### Claim 62

A method of isolating a ligated probe set hybridized to a genetic sample, comprising
contacting a probe set to a genetic sample under a condition effective to hybridize the probe set to a nucleic acid region of interest in nucleotide molecules of the genetic sample, wherein the probe set comprises first and second oligonucleotide probes,
ligating the first and second oligonucleotide probes to form a ligated probe set,
denaturing the ligated probe set from the genetic sample,
hybridizing at least a part of a junction capture probe to the ligated probe set, wherein the junction capture probe is hybridized to (i) at least a part of the first oligonucleotide probe and (ii) at least a part of the second oligonucleotide probe, and
isolating the ligated probe set hybridized to the junction capture probe.

### Claim 63 (depends on 62)

The method according to claim 62, wherein the junction capture probe comprises a tag, and the isolating comprises immobilizing the tag on a substrate and washing the substrate.

### Claim 64 (depends on 63)

The method according to claim 63, wherein the tag is biotin, and the substrate comprises streptavidin.

### Claim 65 (depends on 64)

The method according to claim 64, wherein the substrate comprises a streptavidin magnetic bead.

### Claim 66 (depends on 63, 64, 65)

The method according to any of claims 63-65, wherein the immobilizing the tag is performed prior to the hybridizing the at least a part of a junction capture probe to the ligated probe set, and the washing is performed after the hybridizing.

### Claim 67 (depends on 62, 63, 64, 65, 66)

The method according to any of claims 62-66, wherein the isolating comprises separating the ligated probe set from the substrate.

### Claim 68 (depends on 63)

The method according to claim 63, wherein the substrate comprises an anchor tag, and the immobilizing comprises immobilizing the tag to the anchor tag of the substrate.

### Claim 69 (depends on 68)

The method according to claim 68, wherein the tag of the junction capture probe and the anchor tag of the substrate comprise complementary oligonucleotide sequences, and the immobilizing comprises hybridizing the tag to the anchor tag of the substrate.

### Claim 70 (depends on 62, 63, 64, 65, 66, 67, 68, 69)

The method according to any of claims 62-69, wherein the isolating comprises isolating the ligated probe set hybridized to the junction capture probe from the genetic sample.

### Claim 71 (depends on 62, 63, 64, 65, 66, 67, 68, 69, 70)

The method according to any of claims 62-70, wherein (i) said at least a part of the first oligonucleotide probe hybridized to the junction capture probe and (ii) said at least a part of the second oligonucleotide probe hybridized to the junction capture probe are adjacent to each other.

### Claim 72 (depends on 62, 63, 64, 65, 66, 67, 68, 69, 70, 71)

The method according to any one of claims 62-71, wherein
the ligating comprises (i) raising temperature of the probe set and the nucleotide molecules, and/or (ii) contacting a stabilizing agent to the probe set and the nucleotide molecules.

### Claim 73 (depends on 62, 63, 64, 65, 66, 67, 68, 69, 70, 71)

The method according to any one of claims 62-71, wherein the ligating comprises raising temperature of the probe set and the nucleotide molecules to an increased temperature, and contacting a ligation agent to the probe set at the increased temperature.

### Claim 74 (depends on 62, 63, 64, 65, 66, 67, 68, 69, 70, 71)

The method according to any one of claims 62-71, wherein the ligating comprises raising temperature of the probe set and the nucleotide molecules to an increased temperature, contacting a stabilizing agent to the probe set and the nucleotide molecules, and contacting a ligation agent to the probe set at the increased temperature in the presence of the stabilizing agent.

### Claim 75

A method of detecting a genetic variation in a genetic sample from a subject, comprising
contacting a probe set to a genetic sample under a condition effective to hybridize the probe set to a nucleic acid region of interest in nucleotide molecules of the genetic sample, wherein
the probe set comprises first and second oligonucleotide probes, and
each of the oligonucleotide probes is configured to hybridize to a part of the nucleic acid region of interest,
ligating the first and second oligonucleotide probes that are hybridized to the nucleotide molecules to form a ligated probe set,
denaturing the ligated probe set from the genetic sample,
hybridizing at least a part of a junction capture probe to the ligated probe set, wherein the junction capture probe is hybridized to (i) at least a part of the first oligonucleotide and (ii) at least a part of the second oligonucleotide,
isolating the ligated probe set hybridized to the junction capture probe,
amplifying the ligated probe set to form amplified ligated probe sets, and
detecting the amplified ligated probe sets to determine the presence or absence of the genetic variation in a genetic sample from a subject.

### Claim 76 (depends on 75)

The method according to claim 75, wherein the junction capture probe comprises a tag, and the isolating comprises immobilizing the tag on a substrate and washing the substrate.

### Claim 77 (depends on 76)

The method according to claim 76, wherein the tag is biotin, and the substrate comprises streptavidin.

### Claim 78 (depends on 77)

The method according to claim 77, wherein the substrate comprises a streptavidin magnetic bead.

### Claim 79 (depends on 76, 77, 78)

The method according to any of claims 76-78, wherein the immobilizing the tag is performed prior to the hybridizing the at least a part of a junction capture probe to the ligated probe set, and the washing is performed after the hybridizing.

### Claim 80 (depends on 75, 76, 77, 78, 79)

The method according to any of claims 75-79, wherein the isolating comprises separating the ligated probe set from the substrate.

### Claim 81 (depends on 76)

The method according to claim 76, wherein the substrate comprises an anchor tag, and the immobilizing comprises immobilizing the tag to the anchor tag of the substrate.

### Claim 82 (depends on 81)

The method according to claim 81, wherein the tag of the junction capture probe and the anchor tag of the substrate comprise complementary oligonucleotide sequences, and the immobilizing comprises hybridizing the tag to the anchor tag of the substrate.

### Claim 83 (depends on 75, 76, 77, 78, 79, 80, 81, 82)

The method according to any of claims 75-82, wherein the isolating comprises isolating the ligated probe set hybridized to the junction capture probe from the genetic sample.

### Claim 84 (depends on 75, 76, 77, 78, 79, 80, 81, 82, 83)

The method according to any of claims 75-83, wherein (i) said at least a part of the first oligonucleotide probe hybridized to the junction capture probe and (ii) said at least a part of the second oligonucleotide probe hybridized to the junction capture probe are adjacent to each other.

### Claim 85 (depends on 75, 76, 77, 78, 79, 80, 81, 82, 83, 84)

The method according to any one of claims 75-84, wherein
the ligating comprises (i) raising temperature of the probe set and the nucleotide molecules, and/or (ii) contacting a stabilizing agent to the probe set and the nucleotide molecules.

### Claim 86 (depends on 75, 76, 77, 78, 79, 80, 81, 82, 83, 84)

The method according to any one of claims 75-84, wherein the ligating comprises raising temperature of the probe set and the nucleotide molecules to an increased temperature, and contacting a ligation agent to the probe set at the increased temperature.

### Claim 87 (depends on 75, 76, 77, 78, 79, 80, 81, 82, 83, 84)

The method according to any one of claims 75-84, wherein the ligating comprises raising temperature of the probe set and the nucleotide molecules to an increased temperature, contacting a stabilizing agent to the probe set and the nucleotide molecules, and contacting a ligation agent to the probe set at the increased temperature in the presence of the stabilizing agent.

### Claim 88

A method of detecting a genetic variation in a genetic sample from a subject, comprising
contacting first and second probe sets to the genetic sample under a condition effective to hybridize the probe sets to a nucleic acid region of interest in nucleotide molecules of the genetic sample, wherein
the first probe set comprises a first labeling probe and a first tagging probe, and
the second probe set comprises a second labeling probe and a second tagging probe,
denaturing the ligated probe set from the genetic sample,
ligating at least parts of the first probe set at least by ligating the first labeling probe and the first tagging probe to form a first ligated probe set,
ligating at least parts of the second probe set at least by ligating the second labeling probe and the second tagging probe to form a second ligated probe set,
hybridizing at least a part of each of first and second junction capture probes to the first and second ligated probe sets, respectively, wherein the first junction capture probe is hybridized to at least a part of each of the first labeling probe and the first tagging probe, and the second junction capture probe is hybridized to at least a part of each of the second labeling probe and the second tagging probe,
isolating at least a part of the first and second ligated probe sets that are hybridized to the first and second junction capture probes, respectively, to form first and second isolated ligated probe sets,
amplifying (i) the first isolated ligated probe set with first forward and reverse primers, wherein at least one of the first forward and reverse primers comprises a first label, and (ii) the second isolated ligated probe set with second forward and reverse primers, wherein at least one of the second forward and reverse primers comprises a second label, to form amplified first and second ligated probe sets comprising the first and second labels, respectively, wherein the first and second labels are different,
immobilizing at least parts of the amplified first and second ligated probe sets on a substrate, wherein the first and second labels of the amplified first and second ligated probe sets are optically resolvable after immobilization,
counting (i) a first number of the first label in the amplified first probe set immobilized to the substrate, and (ii) a second number of the second label in the amplified second probe set immobilized to the substrate, and
comparing the first and second numbers to determine the presence or absence of the genetic variation in a genetic sample from a subject.

### Claim 89 (depends on 88)

The method according to claim 88, wherein the junction capture probe comprises a tag, and the isolating comprises immobilizing the tag on a substrate and washing the substrate.

### Claim 90 (depends on 89)

The method according to claim 89, wherein the tag is biotin, and the substrate comprises streptavidin.

### Claim 91 (depends on 90)

The method according to claim 90, wherein the substrate comprises a streptavidin magnetic bead.

### Claim 92 (depends on 89, 90, 91)

The method according to any of claims 89-91, wherein the immobilizing the tag is performed prior to the hybridizing the at least a part of a junction capture probe to the ligated probe set, and the washing is performed after the hybridizing.

### Claim 93 (depends on 88, 89, 90, 91, 92)

The method according to any of claims 88-92, wherein the isolating comprises separating the ligated probe set from the substrate.

### Claim 94 (depends on 89)

The method according to claim 89, wherein the substrate comprises an anchor tag, and the immobilizing comprises immobilizing the tag to the anchor tag of the substrate.

### Claim 95 (depends on 94)

The method according to claim 94, wherein
the tag of the junction capture probe and the anchor tag of the substrate comprise complementary oligonucleotide sequences, and
the immobilizing comprises hybridizing the tag to the anchor tag of the substrate.

### Claim 96 (depends on 88, 89, 90, 91, 92, 93, 94, 95)

The method according to any of claims 88-95, wherein the isolating comprises isolating the ligated probe set hybridized to the junction capture probe from the genetic sample.

### Claim 97 (depends on 88, 89, 90, 91, 92, 93, 94, 95, 96)

The method according to any of claims 88-96, wherein (i) said at least a part of the first oligonucleotide probe hybridized to the junction capture probe and (ii) said at least a part of the second oligonucleotide probe hybridized to the junction capture probe are adjacent to each other.

### Claim 98 (depends on 88, 89, 90, 91, 92, 93, 94, 95, 96, 97)

The method according to any one of claims 88-97, wherein
the ligating comprises (i) raising temperature of the first and second probe sets and the nucleotide molecules, and/or (ii) contacting a stabilizing agent to the first and second probe sets and the nucleotide molecules.

### Claim 99 (depends on 88, 89, 90, 91, 92, 93, 94, 95, 96, 97)

The method according to any one of claims 88-97, wherein the ligating comprises raising temperature of the first and second probe sets and the nucleotide molecules to an increased temperature, and contacting a ligation agent to the first and second probe sets at the increased temperature.

### Claim 100 (depends on 88, 89, 90, 91, 92, 93, 94, 95, 96, 97)

The method according to any one of claims 88-97, wherein the ligating comprises raising temperature of the first and second probe sets and the nucleotide molecules to an increased temperature, contacting a stabilizing agent to the first and second probe sets and the nucleotide molecules, and contacting a ligation agent to the first and second probe sets at the increased temperature in the presence of the stabilizing agent.

### Claim 101

A method of isolating a ligated probe set hybridized to a genetic sample, comprising
contacting a probe set to a genetic sample under a condition effective to hybridize the probe set to a nucleic acid region of interest in nucleotide molecules of the genetic sample, wherein the probe set comprises first and second oligonucleotide probes,
ligating the first and second oligonucleotide probes to form a ligated probe set,
hybridizing at least a part of a junction capture probe to the ligated probe set, wherein the junction capture probe is hybridized to (i) at least a part of the first oligonucleotide probe and (ii) at least a part of the second oligonucleotide probe, and
isolating the ligated probe set hybridized to the junction capture probe.

### Claim 102

A method of detecting a genetic variation in a genetic sample from a subject, comprising
contacting a probe set to a genetic sample under a condition effective to hybridize the probe set to a nucleic acid region of interest in nucleotide molecules of the genetic sample, wherein
the probe set comprises first and second oligonucleotide probes, and
each of the oligonucleotide probes is configured to hybridize to a part of the nucleic acid region of interest,
ligating the first and second oligonucleotide probes that are hybridized to the nucleotide molecules to form a ligated probe set,
hybridizing at least a part of a junction capture probe to the ligated probe set, wherein the junction capture probe is hybridized to (i) at least a part of the first oligonucleotide and (ii) at least a part of the second oligonucleotide,
isolating the ligated probe set hybridized to the junction capture probe,
amplifying the ligated probe set to form amplified ligated probe sets, and
detecting the amplified ligated probe sets to determine the presence or absence of the genetic variation in a genetic sample from a subject.

### Claim 103

A method of detecting a genetic variation in a genetic sample from a subject, comprising
contacting first and second probe sets to the genetic sample under a condition effective to hybridize the probe sets to a nucleic acid region of interest in nucleotide molecules of the genetic sample, wherein
the first probe set comprises a first labeling probe and a first tagging probe, and
the second probe set comprises a second labeling probe and a second tagging probe,
ligating at least parts of the first probe set at least by ligating the first labeling probe and the first tagging probe to form a first ligated probe set,
ligating at least parts of the second probe set at least by ligating the second labeling probe and the second tagging probe to form a second ligated probe set,
hybridizing at least a part of each of first and second junction capture probes to the first and second ligated probe sets, respectively, wherein the first junction capture probe is hybridized to at least a part of each of the first labeling probe and the first tagging probe, and the second junction capture probe is hybridized to at least a part of each of the second labeling probe and the second tagging probe,
isolating at least a part of the first and second ligated probe sets that are hybridized to the first and second junction capture probes, respectively, to form first and second isolated ligated probe sets,
amplifying (i) the first isolated ligated probe set with first forward and reverse primers, wherein at least one of the first forward and reverse primers comprises a first label, and (ii) the second isolated ligated probe set with second forward and reverse primers, wherein at least one of the second forward and reverse primers comprises a second label, to form amplified first and second ligated probe sets comprising the first and second labels, respectively, wherein the first and second labels are different,
immobilizing at least parts of the amplified first and second ligated probe sets on a substrate, wherein the first and second labels of the amplified first and second ligated probe sets are optically resolvable after immobilization,
counting (i) a first number of the first label in the amplified first probe set immobilized to the substrate, and (ii) a second number of the second label in the amplified second probe set immobilized to the substrate, and
comparing the first and second numbers to determine the presence or absence of the genetic variation in a genetic sample from a subject.
